Weiyan Li

Weiyan Li is an experienced epidemiologist currently serving as the Asset Lead (Director) for Oncology Outcomes Research at AstraZeneca. They have previously held positions at institutions such as Johns Hopkins Bloomberg School of Public Health, where they taught and conducted research, and at Evidera and Roche Molecular Diagnostics, where they focused on epidemiology and real-world data analysis. Weiyan's academic credentials include a Ph.D. in Epidemiology from The Johns Hopkins University and an MPH in Epidemiology from Emory University. With a strong background in oncology and precision medicine, they have demonstrated expertise in health economics and outcomes research.